Corrigendum to "Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice" [Atherosclerosis 243/2 (2015) 598-608]

Affiliations

• ¹ Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, Australia.
• ² Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.
• ³ Metabolomics Australia, Bio21 Institute, Parkville, Australia.
• ⁴ Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. Electronic address: judy.dehaan@bakeridi.edu.au.
• ⁵ Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, Australia. Electronic address: peter.meikle@bakeridi.edu.au.